After repeated appeals from public health experts, last month, Australian authorities agreed to set up a special committee on tobacco harm reduction to explore "tobacco reduction strategies", including e-cigarettes.

The committee will analyze strategies successfully adopted by other countries such as the United Kingdom and New Zealand, and their impact on tobacco and nicotine use. Finally, the committee’s goal is to determine Australia’s methods to reduce youth smoking and e-cigarette smoking, and will submit a final report listing the findings of the investigation by December 1, 2020.

The Pharmaceutical Association supports this measure

At the same time, TGA decided to only provide nicotine for e-cigarettes on prescription. Anthony Tasson, president of the Victoria branch of the Pharmacists Association, supported this decision. "The association supports the interim decision to reschedule nicotine and the decision to include nicotine in Schedule 4 drugs."

Such measures make it more difficult for smokers seeking to quit smoking to obtain these products, thereby reducing their chances of success. "Ideally, these products should be registered with the Australian Therapeutic Products Registry. The Association supports this interim decision that liquid nicotine products are appropriately arranged and controlled for therapeutic purposes to support smoking cessation."

He added: "Requirements to register products on ARTG will solve packaging-related issues, as well as safety and quality issues.".

Of course, it is not surprising that the association and other medical institutions will support these measures, because it means that they will benefit financially. On the other hand, these measures make it more difficult for smokers who want to quit smoking to obtain these products, thereby reducing their chances of success.

E-cigarette sales are limited to pharmaceutical companies?

Last month, the National Retailers Association (NRA) condemned the government’s recommendation to the Therapeutic Products Administration to allow only pharmacies to sell smokeless nicotine products. Dominic, CEO of NRA? Lamb (Dominique Lamb) said that this will create a monopoly, which is detrimental to small convenience retailers because they rely heavily on tobacco sales.

Lamb said: "The NRA understands that the Federal Government has asked the Therapeutics Administration to consider whether smokeless nicotine products should be sold in pharmacies, whether by prescription or authorized by a pharmacist."

"It doesn't make sense. You can buy cigarettes for free on the counters of corner shops and service stations, but the products that can help people quit smoking will be restricted. So outside of the working hours of doctors or pharmacists, the only option is cigarettes. This It violates common sense," she added.

Lamb added that excluding small businesses from the safer alternative market in this way puts these businesses at risk, disrupts market dynamics, and has a counterproductive effect on public health.

Prev : Philippine e-cigarette regulation

Next : New Zealand Electronic Cigarette News

Email:sales@mlifevapor.com

WhatsApp:+86 13871529372

Email:sales@mlifevapor.com

WhatsApp:+86 13871529372

Tel：+86 13871529372

Add：6 / F, block B, building 2, Fuyong Tongtai times center, Bao'an District, Shenzhen

Language：简体中文 | >

Tel：+86 13871529372

Add：6 / F, block B, building 2, Fuyong Tongtai times center, Bao'an District, Shenzhen Website